Cargando…

Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab

ABSTRACT: BACKGROUND: Migraine involves central and peripheral nervous system mechanisms. Erenumab, an anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody with little central nervous system penetrance, is effective for migraine prevention. The objective of this study was to dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwedt, Todd J., Nikolova, Simona, Dumkrieger, Gina, Li, Jing, Wu, Teresa, Chong, Catherine D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748909/ https://www.ncbi.nlm.nih.gov/pubmed/36517767 http://dx.doi.org/10.1186/s10194-022-01526-5

Ejemplares similares

Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine
por: Nikolova, Simona, et al.
Publicado: (2023)

The value of brain MRI functional connectivity data in a machine learning classifier for distinguishing migraine from persistent post-traumatic headache
por: Dumkrieger, Gina, et al.
Publicado: (2023)

Clinical correlates of insomnia in patients with persistent post-traumatic headache compared with migraine
por: Kim, Soo-Kyoung, et al.
Publicado: (2020)

Timing and durability of response to erenumab in patients with chronic migraine
por: Tepper, Stewart J., et al.
Publicado: (2021)

Headache classification and automatic biomarker extraction from structural MRIs using deep learning
por: Rahman Siddiquee, Md Mahfuzur, et al.
Publicado: (2022)

Magnetic resonance spectroscopy studies in migraine
por: Nikolova, Simona, et al.
Publicado: (2022)

Early onset of efficacy with erenumab in patients with episodic and chronic migraine
por: Schwedt, Todd, et al.
Publicado: (2018)

The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Altered speech patterns in subjects with post-traumatic headache due to mild traumatic brain injury
por: Chong, Catherine D., et al.
Publicado: (2021)

Mild traumatic brain injury affects the features of migraine
por: Ishii, Ryotaro, et al.
Publicado: (2021)

Correlations between Brain Cortical Thickness and Cutaneous Pain Thresholds Are Atypical in Adults with Migraine
por: Schwedt, Todd J., et al.
Publicado: (2014)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Harmonizing Healthy Cohorts to Support Multicenter Studies on Migraine Classification using Brain MRI Data
por: Yoon, Hyunsoo, et al.
Publicado: (2023)

A longitudinal clinical and MRI evaluation of the treatment with erenumab
por: Coccia, Alberto, et al.
Publicado: (2020)

Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
por: De Matteis, Eleonora, et al.
Publicado: (2022)

Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials
por: Di Tanna, Gian Luca, et al.
Publicado: (2019)

Assessment and characteristics of Erenumab therapy on migraine management
por: Saeed, Haitham, et al.
Publicado: (2022)

Persistent post-traumatic headache vs. migraine: an MRI study demonstrating differences in brain structure
por: Schwedt, Todd J., et al.
Publicado: (2017)

Efficacy and Tolerability of Erenumab for Prevention of Episodic Migraine in India
por: Chowdhury, Debashish, et al.
Publicado: (2022)

Erenumab in the Treatment of Comorbid Trigeminal Neuralgia in Patients With Migraine
por: Katsuki, Masahito, et al.
Publicado: (2023)

Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021)

The Characteristics of White Matter Hyperintensities in Patients With Migraine
por: Chong, Catherine D., et al.
Publicado: (2022)

Efficacy and safety of erenumab in women with a history of menstrual migraine
por: Pavlovic, Jelena M., et al.
Publicado: (2020)

Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
por: Manickam, Agaath Hedina, et al.
Publicado: (2021)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
por: Belvís, Robert, et al.
Publicado: (2021)

A Cross-Study Analysis for Reproducible Sub-classification of Traumatic Brain Injury
por: Si, Bing, et al.
Publicado: (2018)

Structural alterations of the brainstem in migraine
por: Chong, Catherine D., et al.
Publicado: (2016)

Temporal Lobe Cortical Thickness Correlations Differentiate the Migraine Brain from the Healthy Brain
por: Schwedt, Todd J., et al.
Publicado: (2015)

A prospective real-world analysis of erenumab in refractory chronic migraine
por: Lambru, Giorgio, et al.
Publicado: (2020)

Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
por: Raffaelli, Bianca, et al.
Publicado: (2019)

Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
por: Silvestro, Marcello, et al.
Publicado: (2021)

Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
por: Alsaadi, Taoufik, et al.
Publicado: (2022)

Improved Osteoarthritis during Erenumab Treatment for Migraine: A Case Report
por: Jantzen, Frederik Thal, et al.
Publicado: (2023)

The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
por: Filippi, Massimo, et al.
Publicado: (2023)

Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study
por: Lee, Mi Ji, et al.
Publicado: (2019)

The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
por: Ornello, Raffaele, et al.
Publicado: (2019)

One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study
por: Goadsby, Peter J., et al.
Publicado: (2020)

Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial
por: Tepper, Stewart J., et al.
Publicado: (2019)

Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
por: Christensen, Casper Emil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b2q1em3e9o7vqcm23tdbk6ohnf